CDMO for complex fine chemicals – from process development and scale-up to commercial manufacturing
CABB Group GmbH
Pratteln (CH) · Kokkola (FI) · Germany (multiple sites) · ChinaNew on Amplifa
About CABB
CABB Group is a Contract Development and Manufacturing Organization (CDMO) serving the pharmaceutical, life sciences, fine chemicals and crop science industries. The company offers custom manufacturing with a focus on complex, multi-stage chemical syntheses of high purity. The range of services covers the entire value chain: process development, piloting, scale-up and commercial manufacturing, complemented by a portfolio of fine chemicals such as reagents, building blocks and advanced intermediates on a made-to-order or made-to-demand basis, including glycolic acid and dichloroacetic acid (DCA). CABB supplies customers who require high-quality starting materials, intermediates and active pharmaceutical ingredients (APIs). The company operates five production sites in Switzerland, Germany, Finland and China and achieved revenue of €494 million in fiscal year 2025 with around 1,000 employees.
- Site
- Pratteln
- Processes
- Complex multi-stage chemical synthesis (Custom Manufacturing), Process development, Piloting and scale-up, Commercial manufacturing, Manufacture of fine chemicals (reagents, building blocks, advanced intermediates), Custom Manufacturing (CDMO), Piloting, Scale-up
- Materials
- Glycolic acid, Dichloroacetic acid (DCA), Complex multi-stage chemical synthesis, Biorefinery (algae)
- Employees
- around 1,000
- Industries
- Pharma, Life Sciences, Fine Chemicals, Crop Science
- 01
Process development
- 02
Piloting
- 03
Scale-up
- 04
Commercial manufacturing
- 05
Distribution
Products & Processes
Glycolic acid
Fine chemical in the portfolio, distributed via distribution partnerships with Univar Solutions in EMEA and North America.
Dichloroacetic acid (DCA)
Advanced intermediate, among other things for oligonucleotide synthesis, manufactured via specialized synthesis routes.
Complex multi-stage chemical synthesis
Contract manufacturing of high-purity starting materials, intermediates and active ingredients for pharma and crop science.
Biorefinery (algae)
Partnership with Origin by Ocean to commercialize and scale ingredients from invasive brown algae in Finland.
Locations
Pratteln
CHProduction
Kokkola
FIProduction
Germany
DEProduction (multiple sites)
China
CNProduction
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Complex multi-stage chemical synthesis (Custom Manufacturing)Chemistry/Synthesis | – | – | – | – | Fine chemicals, Precursors, Active pharmaceutical ingredients (APIs) |
| Process developmentEngineering | – | – | – | – | – |
| Piloting and scale-upEngineering | – | – | – | – | – |
| Commercial manufacturingChemistry/Synthesis | – | – | – | – | – |
| Manufacture of fine chemicals (reagents, building blocks, advanced intermediates)Chemistry/Synthesis | – | – | – | – | Glycolic acid, Dichloroacetic acid (DCA) |
Additional services
Reference customers
History
- 2025
Revenue of €494 million; Tobias Schalow takes over the CEO role from Thomas H. Ahrens in September; Marcus Mayer becomes the new CFO.
Successful completion of the refinancing of CABB Group.
Sale of Jayhawk Fine Chemicals Corporation to Anupam Rasayan India Ltd.
Algae biorefinery partnership with Origin by Ocean in Finland.
Expansion of the distribution partnership with Univar Solutions for glycolic acid to EMEA and North America.